Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

iCAD, Inc.

ICADNASDAQ
Healthcare
Medical - Devices
$3.87
$0.14(3.75%)
U.S. Market opens in 23h 56m

iCAD, Inc. (ICAD) Stock Overview

Explore iCAD, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap106.3M
P/E Ratio-29.64
EPS (TTM)$-0.19
ROE-0.12%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$4.58

ICAD Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of iCAD, Inc. (ICAD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $4.58.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -29.64 and a market capitalization of 106.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-3.01%
6-Month Change
16.57%
Year-to-Date (YTD) Change
94.47%
1-Year Change
130.36%
3-Year Change
13.49%
5-Year Change
-62.97%
All-Time (Max) Change
-90.01%

Contact Information

603 882 5200
98 Spit Brook Road, Nashua, NH, 03062

Company Facts

660 Employees
IPO DateDec 13, 1984
CountryUS

Frequently Asked Questions